Results 11 to 20 of about 35,740 (128)

Prazosin: Benign Prostatic Hyperplasia [PDF]

Hospital Pharmacy, 2010
This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration.
Joyce A, Generali, Dennis J, Cada
openaire   +2 more sources

Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen

Indian Journal of Pathology and Microbiology, 2011
Background: Hepsin (HPN), a type II trans-membrane serine protease, has been reported to be one of the most up regulated genes in prostate cancer. The aim of the present study was to find out immuno-histochemistry based phenotypic expression of HPN in ...
Madhu Mati Goel, Dhamita Agrawal, S M Natu, Apul Goel   +3 more
doaj   +1 more source

Huge Benign Prostatic Hyperplasia

Urology Journal, 2004
Seyed Yousef Hosseini, Mohammad Reza Safarinejad   +1 more
doaj   +3 more sources

Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats.

PLoS ONE, 2022
Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels ...
Jinho An, Hyunseok Kong
doaj   +1 more source

Role of gangliosides in prostate pathology [PDF]

Romanian Journal of Infectious Diseases, 2016
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae, Corina-Daniela Ene, Simona Roxana Georgescu   +2 more
doaj   +1 more source

Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.

Molecules, 2015
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu, Hua-Guo Chen, Xin Zhou, Ya Huang, En-Ming Hu, Zheng-Meng Jiang, Chao Zhao, Xiao-Jian Gong, Qing-Fang Deng   +8 more
doaj   +1 more source

Quantitation of α_1A and α_1D-adrenoceptor mRNA in prostate tissues from patients with symptomatic benign prostatic hyperplasia

Journal of Pathology of Nepal, 2011
Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya, H Okada, G Aryal, T Shirakawa, N Hinata, A Gotoh   +5 more
doaj   +1 more source

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia

Prostate International, 2018
Background: To investigate the effect of asymptomatic inflammatory prostatitis on clinical outcomes of patients undergoing trans urethral resection of prostate due to benign prostatic hyperplasia.
Suleyman Sami Cakir, Emre Can Polat, Levent Ozcan, Huseyin Besiroglu, Alper Ötunctemur, Emin Ozbek   +5 more
doaj   +1 more source

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study

Military Medical Research, 2019
Background Both periodontal disease and benign prostatic hyperplasia are age-related diseases that affect millions of people worldwide. Hence, this study aimed to investigate the association between periodontal disease and the risk of benign prostatic ...
Lan Wu, Bing-Hui Li, Yun-Yun Wang, Chao-Yang Wang, Hao Zi, Hong Weng, Qiao Huang, You-Jia Zhu, Xian-Tao Zeng   +8 more
doaj   +1 more source

Immunohistochemical Expression of Nkx3.1 in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia at a Tertiary Care Hospital in Karachi

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To determine NKX3.1 expression in prostatic adenocarcinoma and benign prostate hyperplasia on Immunohistochemistry at a tertiary care hospital in Karachi.
Beenish Hussain, Syeda Naveera Raza, Amna Hussain, Ramsha Faridi, Saman Nadeem, Yusra Saleem   +5 more
doaj   +1 more source